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E-mail address: epand@mcmaster.ca (R.M. Epand)We show that diacylglycerol kinase-e (DGKe) has less preference for the acyl chain at the sn-1 posi-
tion of diacylglycerol (DAG) than the one at the sn-2 position. Although DGKe discriminates between
1-stearoyl-2-arachidonoyl-DAG and 1-palmitoyl-2-arachidonoyl-DAG, it has similar substrate pref-
erence for 1-stearoyl-2-arachidonoyl-DAG and 1,2-diarachidonoyl-DAG. We suggest that in addition
to binding to the enzyme, the acyl chain at the sn-1 position may contribute to the depth of insertion
of the DAG into the membrane. Thus, the DAG intermediate of the PI-cycle, 1-stearoyl-2-arachido-
noyl-DAG, is not the only DAG that is a good substrate for DGKe, the DGK isoform involved in
PI-cycling.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Diacylglycerol kinases (DGKs) phosphorylate diacylglycerol
(DAG), a second messenger involved in cell signaling, to produce
phosphatidic acid (PA), which has signaling roles as well [1]. It is
now widely accepted that conversion of DAG to PA by DGKs is
the major pathway to remove the potent signaling molecule DAG.
It appears that the physiologically relevant DAGs are those
containing a polyunsaturated acyl chain in the sn-2 position.
DGKe is the only DGK isoform that shows substrate speciﬁcity
in vitro for DAG with an arachidonoyl acyl chain at the sn-2 posi-
tion [2,3]. Phosphorylation of 1-stearoyl-2-arachidonoyl-DAG
(18:0/20:4-DAG), catalyzed by DGK, is the ﬁrst step in the resyn-
thesis of phosphatidylinositol (PI). It was shown that among all
the isoforms of DGK, DGKe appears to be the most important
for catalyzing this step in the PI cycle, since deletion of this en-
zyme signiﬁcantly decreases the amounts of both PI and PA in
the plasma membrane of the cells [4]. 1-stearoyl-2-arachido-chemical Societies. Published by E
cylglycerol; PA, phosphatidic
8:0/20:4-DAG, 1-stearoyl-2-
yl-DAG; DHA, docosahexae-
.noyl-DAG is formed as a result of phosphatidylinositol-4,5-bis-
phosphate-speciﬁc phospholipase C catalyzed hydrolysis of
phosphatidylinositol-4,5-bisphosphate that itself is highly en-
riched in arachidonic acid at the same position. Thus, DGKe
may be responsible for down-regulating the DAG signaling result-
ing from phosphatidylinositol cycling.
The product of the reaction catalyzed by DGK, PA, is also in-
volved in the regulation of a wide variety of cellular events,
including cell survival, cytoskeletal rearrangement, and prolifera-
tion [5]. It is believed that each PA species can differentially acti-
vate proteins depending on the saturation and length of the acyl
chains [6]. It was shown that the PA produced by different DGKs
can fulﬁll different roles in the cell. Thus, PA produced by DGKe is
enriched in polyunsaturated fatty acids, particularly arachidonate,
and it is involved in the PI cycle. PA produced by DGKa is neces-
sary to progress to S phase of the cell cycle in stimulated T lym-
phocytes [7] and PA produced by DGKf is involved in the
initialization of the cascade to cause actin rearrangements [8].
Therefore, DGK substrate speciﬁcity is crucial for the regulation
of many cellular processes. In the present work, we studied the
substrate speciﬁcity of DGKe and for the ﬁrst time showed that
the DAG intermediate of the PI cycle, 1-stearoyl-2-arachidonoyl-
DAG (18:0/20:4-DAG), is not the only preferred substrate for
DGKe, but that this enzyme exhibits similar preference towards
1,2-diarachidonoyl-DAG (20:4/20:4-DAG).lsevier B.V. All rights reserved.
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2.1. Preparation of Sf21 cells overexpressing DGKe and DGKf
Baculovirus-infected Sf21 cells overexpressing either human
DGKe with a C-terminal hexahistidine (DGKe-His6) or DGKf with
a C-terminal FLAG epitope (DGKf-FLAG) were prepared as previ-
ously described [9].
2.2. Enzyme preparations for enzymatic activity assay
Prior to assay, baculovirus-infected Sf21 cells overexpressing
either human DGKe-His6 or DGKf-FLAG were resuspended in ice-
cold cell lysis buffer (1% (v/v) (octylphenoxy)polyethoxyethanol
(Nonidet P-40), 20 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1 mM
EDTA, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate,
1 mM activated sodium orthovanadate, and 1:100 protease inhibi-
tor cocktail for use with mammalian cells and tissue (Sigma–
Aldrich)), allowed to lyse for 10 min on ice, sonicated for 5 min
and then centrifuged at 100000g, 30 min at 4 C. The supernatants
were used in the assay of DGK activity.
2.3. Quantiﬁcation of phosphatidic acid
The concentration of all PA stocks used in this study was deter-
mined experimentally based on their phosphate content, as de-
scribed previously [10].
2.4. Detergent-phospholipid-mixed micelle-based DGK enzymatic
activity assay
DGK was assayed for enzymatic activity using a detergent-
phospholipid-mixed micelle-based protocol described by Walsh
et al. [2] as previously employed in our laboratory [11]. Lipid ﬁlms
composed of the substrate (DAG) and 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC, for DGKe) or 1,2-dioleoyl-sn-glycero-3-
[phospho-L-serine] (DOPS, for DGKf)) were prepared. Enzymatic
activity was measured with 15 mM Triton X-100, 0.1 mM [c-32P]-
ATP, 1.52 mol% DAG and 22.5 mol% DOPC or 22.5 mol% DOPS. The
assays were performed in triplicate and the results are presented
as the mean ± S.D.
2.5. Kinetic analysis of the micelle-based assay of DGK activity
The Michaelis–Menten constants, Vmax and Km, were evaluated
by a non-linear regression analysis (initial velocity (v0) versus sub-
strate concentration ([S])), as well as by using Hanes plots ([S]/v0
versus [S]). Origin (version 7.5) software was used to determine
Vmax and Km parameters. Inhibition by PA was observed to be com-
petitive, in agreement with previous observations [12]. Ki con-
stants were evaluated by a non-linear regression analysis for a
competitive type of enzyme inhibition, using the GraphPad Prism
software program (version 5.04).Fig. 1. Comparison of the enzyme activities for DGKe with 18:0/20:4-DAG, 20:4/
20:4-DAG, 18:0/18:2-DAG, and 18:2/18:2-DAG as substrates. Negative control (EV)
is performed with the lysates from mock baculovirus-infected Sf21 cells.3. Results and discussion
It has been recognized earlier that DGKe exhibits speciﬁcity for
arachidonoyl-containing forms of DAG [13]. It has more recently
been established that this isoform of DGK has a particularly impor-
tant role in catalyzing one of the steps of the PI-cycle [3,14]. This
ﬁnding correlated well with the known arachidonoyl speciﬁcity,
since the predominant acyl chain in the sn-2 position of lipid inter-
mediates of the PI-cycle is arachidonic acid. It is also established
that these PI-cycle lipid intermediates contain predominantly
stearoyl chains at the sn-1 position. We have shown that amongsaturated acyl chains, the stearoyl (18:0) chain is the most fa-
voured for substrates of DGKe [12]. Furthermore, there is a de-
crease in 18:0 chains in PIs species in mouse embryo ﬁbroblasts
that have been knocked out for DGKe [12]. Thus the best substrate
that we found for DGKe was 18:0/20:4-DAG, the form of DAG that
is a precursor for the synthesis of PIs. The result of the present
study, that 20:4/20:4-DAG has a similar activity to 18:0/20:4-
DAG (Fig. 1 and Table 1) was surprising. We therefore studied in
more detail the acyl chain requirements for the substrates of DGKe.
Maintaining 18:0 as the sn-1 acyl chain, we conﬁrmed that a
linoleoyl chain (18:2) at the sn-2 position is also a substrate for
DGKe, but one that is poorer than 18:0/20:4-DAG (Fig. 1). Although
18:0 at sn-1 of DAG makes a better DGKe substrate than 16:0, the
difference is not very great [12]. However, 16:0/16:0-DAG is a poor
substrate for DGK [15,16]. We showed that 16:0/18:1-DAG and
18:1/18:1-DAG are also poor substrates (Fig. 2). DGKe is very abun-
dant in the brain and retina, suggesting an important physiological
role of this enzyme in CNS and visual function. At the same time,
docosahexaenoic acid (DHA, 22:6-fatty acid) is the most abundant
omega-3 fatty acid in the brain and retina, comprising 40% of the
polyunsaturated fatty acids in the brain and 60% in the retina. De-
spite these facts, 18:0/22:6-DAG is not a substrate for DGKe
(Fig. 3A). This is in contrast with the behavior of another DGK iso-
form, DGKf, that does not discriminate among DAGs with different
acyl chains (Fig. 3B). Thus, for DGKe there is a very high speciﬁcity
for the acyl chain at the sn-2 position with only two acyl groups,
arachidonoyl or linoleoyl, showing any substantial activity. Inter-
estingly, these two acyl chains are also the only two that are recog-
nized by lipoxygenases. Generally mammalian lipoxygenases are
more speciﬁc for arachidonic acid, while the homologous enzymes
from plants have greater speciﬁcity for linoleic acid. Recognition of
polyunsaturated acyl chains by both DGKe and by lipoxygenases is
due in part to a common amino acid motif in a segment of both
proteins [17].
The requirements for the acyl chain of DAG at the sn-1 position
are much more ﬂexible as shown by the ﬁnding that 20:4/20:4-
DAG has similar activity to 18:0/20:4-DAG (Fig. 1 and Table 1).
Although, with 20:4 in the sn-2 position, 18:0 was the best acyl
chain for sn-1 among saturated acyl chains and had a higher afﬁn-
ity with DGKe than either 16:0/20:4-DAG or 20:0/20:4-DAG [12],
the 18:0 acyl chain at sn-1 can be replaced by 20:4 with almost
complete retention of activity. Furthermore, 18:2/18:2-DAG has a
higher activity than even 18:0/18:2-DAG (Fig. 1). 18:2/18:2-DAG
is also the precursor for PA with this acyl chain composition.
Table 1
Summary of the kinetic parameters for DGKe with 18:0/20:4-DAG, 20:4/20:4-DAG
and 18:2/18:2-DAG as substrates. Results are presented as the mean ± S.D. Values of
Vmax are relative values since the absolute amount of enzyme in the cell preparations
is not known.
Substrate Km (mol%) Vmax (nmol PA min-1) Vmax/Km (mol%1s1)
18:0/20:4 DAG 2.0 ± 0.7 1.7 ± 0.3 0.8 ± 0.3
20:4/20:4 DAG 2.0 ± 0.7 1.6 ± 0.2 0.8 ± 0.3
18:2/18:2 DAG 3.5 ± 0.4 0.89 ± 0.06 0.26 ± 0.03
Fig. 2. Comparison of the enzyme activities for DGKe with 18:0/20:4-DAG, 18:1/
18:1-DAG, and 16:0/18:1-DAG as substrates. Negative control (EV) is performed
with the lysates from mock baculovirus-infected Sf21 cells.
Fig. 4. Comparison of inhibition of DGKe by PAs in presence of different substrates.
DGKe enzymatic activity was measured with 15 mM Triton X-100, 0.1 mM [c-32P]-
ATP, 30 mol% DOPC, and 1.34 mol% either 18:0/20:4-DAG, 20:4/20:4-DAG, and
18:1/18:1-DAG (shown as black bars) or with the addition of either 0.67 mol% 18:0/
20:4-PA (grey bars), 20:4/20:4-PA (light grey bars), or 18:1/18:1-PA (white bars).
Table 2
Summary of the inhibition constants Ki for DGKe with
18:0/20:4-DAG and 20:4/20:4-DAG as substrates and
20:4/20:4-PA as inhibitor. Results are presented as the
mean ± S.D.
Substrate Ki, mol%
18:0/20:4-DAG 4.4 ± 1.0
20:4/20:4-DAG 2.6 ± 0.3
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Studies of the crystal structure of different fatty acids bound to
autotaxin has shown that acyl chains containing unsaturation turn
sharply at the unsaturated bonds, allowing longer lipid tails to be
accommodated in a hydrophobic pocket [19]. A similar phenome-
non can explain the ﬁnding that longer acyl chains can be incorpo-
rated into the sn-1 position of DAG and still be a good substrate for
DGKe, provided that the longer chains have unsaturation.
Another factor that may affect the efﬁciency of phosphorylation
of different species of DAG is the extent to which the substrate
penetrates into the membrane. It is suggestive that this may be a
factor, although at the present time the evidence is incomplete
and indirect. There is however evidence from neutron diffraction
studies showing that the position of tocopherol in a lipidFig. 3. (A) Comparison of the enzyme activities for DGKe with 18:0/20:4-DAG and 18:0
mock baculovirus-infected Sf21 cells. (B) Comparison of the enzyme activities for DG
substrates. Negative control (EV) is performed with the lysates from mock baculovirus-environment is very similar for tocopherol embedded into 20:4/
20:4-PC as it is when embedded in 16:0/20:4-PC and different from
results with other forms of PC not containing polyunsaturated acyl
chains [20]. Thus, replacement of 16:0 in the sn-1 position with a
20:4 chain does not alter the depth of burial of tocopherol and thus
this change of acyl group would also not likely effect the depth of
burial of DAG, despite the large difference in structure and proper-
ties of these acyl groups. The similar location of 18:0/20:4-DAG
and 20:4/20:4-DAG in the membrane can contribute to their sim-
ilar location with respect to the enzyme active site, resulting in
similar activities.
Previously we showed that 18:0/20:4-PA is the best inhibitor of
DGKe [12]. We tested if DGKe inhibition by this PA depends on the
acyl chains of the substrate. Our results showed that 18:0/20:4-PA/22:6-DAG as substrates. Negative control (EV) is performed with the lysates from
Kf with 18:0/20:4-DAG, 18:1/18:1-DAG, 18:0/22:6-DAG, and 20:4/20:4-DAG as
infected Sf21 cells.
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substrates 18:0/20:4-DAG, 20:4/20:4-DAG, and 18:1/18:1-DAG
(Fig. 4). Further, we determined the inhibition constants Ki for
20:4/20:4-PA as an inhibitor of DGKe activity with 18:0/20:
4-DAG and 20:4/20:4-DAG as substrates (Table 2). Comparison of
Ki suggests that 20:4/20:4-PA binds and inhibits DGKe activity to
a somewhat greater extend with 20:4/20:4-DAG as a substrate
than 18:0/20:4-DAG. PA is a competitive inhibitor of DAG phos-
phorylation [12]. Thus, the potency of inhibition of different spe-
cies of PA depends on how well that PA binds to the active site
of DGKe. In contrast, to be a good substrate, the DAG must not only
bind to the active site, but must also be at an optimal location with
regard to the catalytic groups of the enzyme to undergo efﬁcient
catalysis. We suggest that 20:4/20:4-DAG is at the optimal location
for catalysis because its depth of insertion into the membrane is
optimal and therefore it is a good substrate, even though it does
not bind optimally to the enzyme. Furthermore, with 20:4/20:
4-PA, inhibition is slightly stronger because of lower binding of
the substrate to the enzyme.
In summary, our results demonstrate that 18:0/20:4-DAG is not
unique in being a good substrate for DGKe and that there is a qual-
itative difference between the nature and extent of acyl chain spec-
iﬁcity of DGKe for the sn-1 and sn-2 positions of the substrate.
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